We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
This consultation seeks views on proposals to enable pharmacist flexibilities when dispensing medicines.
First published during the 2024 to 2026 Starmer Labour government
Call for evidence to support ACMD's review of changes to legislation on the use of cannabis-based products for medicinal purposes (CBPMs).
This consultation seeks views on draft secondary legislation to provide an explicit exemption for brand advertising from the advertising restrictions for less healthy food or drink on TV and online.
A departmental minute in relation to the insolvency of integrated community equipment supplier NRS Healthcare.
The MHRA invite feedback on the use of designated standards for medical devices and in vitro diagnostic (IVD) devices to help shape future initiatives.
Seeks views on extending the range of medicines available to optometrists and contact lens opticians so they can treat minor eye conditions in the community.
Consultation on proposals to update the MHRA's statutory fees to ensure they continue to recover their costs.
This plan sets out how the Wales Office plans to improve the use of British Sign Language (BSL) in its communications in the next 5 years.
Call for evidence to support ACMD's review of the misuse and harms of gabapentin and pregabalin.
This document details the Government's response to the recommendations made by the Infected Blood Inquiry
DHSC and NHS England’s ongoing work and future plans to improve shortage management and strengthen medicines supply chain resilience.
This call for evidence seeks views on how the current system operates in relation to patient access to medicines through private (non-NHS) routes.
The MHRA is consulting with UK stakeholders to gather feedback and comments on a revised international guideline, M4Q(R2).
Impact assessment and equality impact assessment of human papillomavirus (HPV) self-sampling in the NHS Cervical Screening Programme.
We are seeking your views on what procedures should be in scope of the licensing scheme for non-surgical cosmetic procedures in England.
This consultation seeks views on extending medicines responsibilities for paramedics, physiotherapists, operating department practitioners and diagnostic radiographers.
The Advisory Council on the Misuse of Drugs (ACMD) is calling for evidence on ketamine use, harms and interventions.
An update on progress the government has made to go beyond implementing the Lord O'Shaughnessy review of commercial clinical trials and how it is going further and faster to transform the UK clinical research system.
Impact assessment and equality impact assessment of risk stratification in the NHS Cervical Screening Programme in England.
Sets out the government’s 10 Year Health Plan for England.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).